<amendment session="110" chamber="s" number="983" updated="2022-02-03T05:23:53Z">
  <amends type="s" number="1082" sequence=""/>
  <status datetime="2007-05-08">withdrawn</status>
  <sponsor bioguide_id="V000127"/>
  <offered datetime="2007-05-01"/>
  <description>To require counterfeit-resistant technologies for prescription drugs.</description>
  <actions>
    <action datetime="2007-05-08">
      <text>Proposed amendment SA 983 withdrawn in Senate.</text>
    </action>
    <action datetime="2007-05-08">
      <text>Considered by Senate.</text>
      <reference ref="CR S5682" label="consideration"/>
    </action>
    <action datetime="2007-05-07">
      <text>Considered by Senate.</text>
      <reference ref="CR S5634" label="consideration"/>
    </action>
    <action datetime="2007-05-03">
      <text>Considered by Senate.</text>
      <reference ref="CR S5526" label="consideration"/>
    </action>
    <action datetime="2007-05-02">
      <text>Amendment SA 983 proposed by Senator Vitter. (consideration: CR S5482-5485; text: CR S5482-5483) To require counterfeit-resistant technologies for prescription drugs.</text>
    </action>
    <action datetime="2007-05-02">
      <text>Senate amendment proposed (on the floor): Amendment SA 983 proposed by Senator Vitter.</text>
      <reference ref="CR S5482-5485" label="consideration"/>
      <reference ref="CR S5482-5483" label="text"/>
    </action>
    <action datetime="2007-05-01">
      <text>Senate amendment submitted</text>
    </action>
  </actions>
</amendment>
